Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that the Nomination, Remuneration and Compensation Committee (the ‘Committee’) on November 16, 2022 of the Company has granted stock options as details enclosed.
The above information is a part of company’s filings submitted to BSE.